Wireless Brain Implant to Give Sight to Blind

Scientists in Australia are gearing up for clinical trials of a brain implant that may restore limited sight in blind people. Developed at Monash University in Melbourne, the Gennaris system involves bypassing the eye completely and targeting the vis...
Source: Medgadget - Category: Medical Devices Authors: Tags: Neurology Neurosurgery Ophthalmology Rehab Source Type: blogs

Related Links:

This study defines a new clinically relevant concept of T-cell senescence-mediated inflammatory responses in the pathophysiology of abnormal glucose homeostasis. We also found that T-cell senescence is associated with systemic inflammation and alters hepatic glucose homeostasis. The rational modulation of T-cell senescence would be a promising avenue for the treatment or prevention of diabetes. Intron Retention via Alternative Splicing as a Signature of Aging https://www.fightaging.org/archives/2019/03/intron-retention-via-alternative-splicing-as-a-signature-of-aging/ In recent years researchers have inv...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Hug shirts, smellphones, virtual tastes, bionic eyes and hearing aids doing translations – just a few keywords showing how technology will take human perception to a higher level in the future. Innovative healthcare solutions will go way beyond improving our senses when we experience problems, they will augment our capabilities and open new horizons for humanity. Let’s jump into the pool of details. How humans perceive the sensory cacophony called the world Car. Flower. Smartphone. Leaf. Shadow. Ponytail. Red Sweater. Monitor. Water. Coffee. Beeps. Sidney Bechet tunes. Bicycle. Laugh. Light breeze. Holiday mem...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Biotechnology Cyborgization Health Sensors & Trackers Medical Professionals Patients body augmentation future Healthcare hearing human human perception Medicine sense sensing smell taste touch vision Source Type: blogs
GenSight Biologics, a biopharmaceutical company based in France, is developing gene therapies for rare diseases that cause blindness. The company has recently received approval in the UK for its Phase I/II PIONEER trial, which will test a treatment c...
Source: Medgadget - Category: Medical Devices Authors: Tags: Exclusive Genetics Ophthalmology Source Type: blogs
The Argus II Retinal Prosthesis System (Second Sight Medical Products, Sylmar, CA) is a surgically implantable device designed to provide artificial vision to patients with outer retinal degenerative diseases, especially retinitis pigmentosa (RP). The system was first assessed in 30 blind subjects, 28 of whom had end-stage RP, in an international clinical trial.1 The patients were evaluated by color fundus photography, fluorescein angiography (FA), and optical coherence tomography (OCT) during the follow-up, and the long-term safety results were found acceptable. After U.S. Food and Drug
Source: Ophthalmic Surgery, Lasers and Imaging : the Official Journal of the International Society for Imaging in the Eye - Category: Opthalmology Authors: Source Type: research
Second Sight Medical (NSDQ:EYES) said today it entered the Russian market, with the 1st patient treated with its Argus II Retinal Prosthesis System in Moscow. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception of light patterns to the brain, the Sylmar, Calif.-based company said. The 1st implant was performed at the Federal State Institution &Clinical Research Center of the Federal Medico-Biological Agency at the end of June 2017 by a team of surgeons, with Dr. Paulo Stanga o...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Optical/Ophthalmic second-sight-medical Source Type: news
MEDFORD (CBS) — After 20 years of darkness, there is light. It seems like science fiction, but a bionic eye implant is bringing a kind of sight to the blind. It’s not what you and I see, but for a small number of people, it’s making all the difference. “It’s not actual vision. It’s what they call artificial vision,” says Anthony Andreotolla, one of the first people to ever receive a bionic eye. Every day he puts on his gear, leaves his Medford home and rides the MBTA to his job in Downtown Crossing. Anthony Andreotolla wearing bionic eye (WBZ-TV) Andreotolla has retinitis pigm...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Local News Seen On WBZ-TV Syndicated Local Bionic Eye Medford Paula Ebben Second Sight Source Type: news
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Today, being blind does not scare me. It hasn’t scared me for more than a decade. I must remind myself that this aspect of my existence, which is like any other as far as I am concerned, stands out for others like a baby on a battlefield—and is terrifying to them. I have to remind myself that years ago I, too, was terrified. Of course I can remember the fear. But I remember it the same way you might remember cowering in your bed at night as a child, frightened of the monster under your bed. You now understand there never was a monster, that your fear was irrational, self-imposed, the product of your imagination...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Inspiration & Hope Personal Publishers Self-Help Spirituality & Health afraid anxiety Awfulizing Catastrophizing Challenges Control Denial Destiny Doom Emotions Empowerment Enabler excuses Fear happy Imagination I Source Type: blogs
Terumo Corp. (TYO:4543) said yesterday it tapped Rob DeRyke as its new CV group prez &CEO, effective April 1, 2017, succeeding a retiring Mark Sutter. Prior to his appointment, DeRyke operated as Terumo CV group electromechanical systems division prez, the company said. “Under his leadership, Rob brought stability and improved profitability to the business,” Terumo Corp prez &CEO Shinjiro Sato said in a press release. DeRyke joined Terumo in 2012 as corporate quality VP, and has 25 years of experience in med device and pharmaceuticals, the company said. He has previously held positions at Baxt...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Active Implants AdvaMed Alphatec Holdings Inc. Anika Therapeutics Inc. Apollo Endosurgery Aurora Spine Baxter Biocorp Biogen Idec Biolase Technology Inc Bioventus LLC Bonesupport Clal Biotech Delcath Sys Source Type: news
Second Sight Medical (NSDQ:EYES) said today that the U.K.’s National Health Service granted reimbursement for the company’s Argus II retinal prosthesis system for blind patients with retinitis pigmentosa. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception of light patterns to the brain, the company said. The U.K.’s NHS said that “a selective group of severely blind patients with Retinits Pigementosa can have access to the Argus II,” according to Second Si...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Optical/Ophthalmic Second Sight Medical Products Inc. Source Type: news
More News: Australia Health | Brain | Clinical Trials | Computers | Environmental Health | Eye Implants | Eyes | Hypermetropia (long sighted) | Medical Devices | Neurology | Neurosurgery | Opthalmology | Retinitis Pigmentosa | Study